Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association.

IF 5.2 3区工程技术 Q2 ENERGY & FUELS

Energy & Fuels Pub Date : 2024-10-14 DOI:10.1161/cir.0000000000001290

Rakesh Gopinathannair,Brian Olshansky,Mina K Chung,Steve Gordon,Jose A Joglar,Gregory M Marcus,Philip L Mar,Andrea M Russo,Uma N Srivatsa,Elaine Y Wan,

{"title":"Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association.","authors":"Rakesh Gopinathannair,Brian Olshansky,Mina K Chung,Steve Gordon,Jose A Joglar,Gregory M Marcus,Philip L Mar,Andrea M Russo,Uma N Srivatsa,Elaine Y Wan,","doi":"10.1161/cir.0000000000001290","DOIUrl":null,"url":null,"abstract":"Cardiac arrhythmias are commonly noted in patients during infections with and recovery from COVID-19. Arrhythmic manifestations span the spectrum of innocuous and benign to life-threatening and deadly. Various pathophysiological mechanisms have been proposed. Debate continues on the impact of incident and exacerbated arrhythmias on the acute and chronic (recovery) phase of the illness. COVID-19 and COVID-19 vaccine-associated myocardial inflammation and autonomic disruption remain concerns. As the pandemic has transformed to an endemic, with discovery of new SARS-CoV-2 variants, updated vaccines, and potent antiviral drugs, vigilance for COVID-19-associated arrhythmic and dysautonomic manifestations remains. The objective of this American Heart Association scientific statement is to review the available evidence on the epidemiology, pathophysiology, clinical presentation, and management of cardiac arrhythmias and autonomic dysfunction in patients infected with and recovering from COVID-19 and to provide evidence-based guidance. The writing committee's consensus on implications for clinical practice, gaps in knowledge, and directions for future research are highlighted.","PeriodicalId":35,"journal":{"name":"Energy & Fuels","volume":null,"pages":null},"PeriodicalIF":5.2000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Energy & Fuels","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/cir.0000000000001290","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENERGY & FUELS","Score":null,"Total":0}

引用次数: 0

Abstract

Cardiac arrhythmias are commonly noted in patients during infections with and recovery from COVID-19. Arrhythmic manifestations span the spectrum of innocuous and benign to life-threatening and deadly. Various pathophysiological mechanisms have been proposed. Debate continues on the impact of incident and exacerbated arrhythmias on the acute and chronic (recovery) phase of the illness. COVID-19 and COVID-19 vaccine-associated myocardial inflammation and autonomic disruption remain concerns. As the pandemic has transformed to an endemic, with discovery of new SARS-CoV-2 variants, updated vaccines, and potent antiviral drugs, vigilance for COVID-19-associated arrhythmic and dysautonomic manifestations remains. The objective of this American Heart Association scientific statement is to review the available evidence on the epidemiology, pathophysiology, clinical presentation, and management of cardiac arrhythmias and autonomic dysfunction in patients infected with and recovering from COVID-19 and to provide evidence-based guidance. The writing committee's consensus on implications for clinical practice, gaps in knowledge, and directions for future research are highlighted.

查看原文本刊更多论文

与 COVID-19 有关的心律失常和自主神经功能障碍：美国心脏协会的科学声明。

在感染 COVID-19 和从 COVID-19 恢复的过程中，患者通常会出现心律失常。心律失常的表现范围很广，既有无害的良性表现，也有危及生命的致命表现。人们提出了各种病理生理机制。关于偶发和加重的心律失常对疾病急性期和慢性期（恢复期）的影响的争论仍在继续。COVID-19 和 COVID-19 疫苗相关的心肌炎症和自律神经紊乱仍然令人担忧。随着 SARS-CoV-2 新变种的发现、疫苗的更新和强效抗病毒药物的使用，该流行病已转变为地方性流行病，因此仍需警惕 COVID-19 相关的心律失常和自主神经功能紊乱表现。本美国心脏协会科学声明旨在回顾有关 COVID-19 感染者和康复者心律失常和自主神经功能障碍的流行病学、病理生理学、临床表现和管理的现有证据，并提供循证指导。文中强调了编写委员会就临床实践意义、知识差距和未来研究方向达成的共识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Energy & Fuels 工程技术-工程：化工

CiteScore

9.20

自引率

13.20%

发文量

1101

审稿时长

2.1 months

期刊介绍： Energy & Fuels publishes reports of research in the technical area defined by the intersection of the disciplines of chemistry and chemical engineering and the application domain of non-nuclear energy and fuels. This includes research directed at the formation of, exploration for, and production of fossil fuels and biomass; the properties and structure or molecular composition of both raw fuels and refined products; the chemistry involved in the processing and utilization of fuels; fuel cells and their applications; and the analytical and instrumental techniques used in investigations of the foregoing areas.